Yüklüyor......
Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children
BACKGROUND: The rise in community-acquired urinary tract infections (UTIs) with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli strains raises the question of how to treat these infections effectively in pediatric outpatients. Amikacin has shown promising in vitro activity against ES...
Kaydedildi:
| Yayımlandı: | Infect Drug Resist |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5674974/ https://ncbi.nlm.nih.gov/pubmed/29138582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S148703 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|